Meteora Capital’s Envoy Medical Warrant COCHW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-133,769
Closed -$2.67K 279
2023
Q4
$2.67K Hold
133,769
﹤0.01% 257
2023
Q3
$11.9K Hold
133,769
﹤0.01% 248
2023
Q2
$6.25K Hold
133,769
﹤0.01% 270
2023
Q1
$4.15K Hold
133,769
﹤0.01% 337
2022
Q4
$5.08K Buy
133,769
+26,819
+25% +$1.27K ﹤0.01% 262
2022
Q3
$7K Buy
106,950
+15,000
+16% +$1.36K ﹤0.01% 285
2022
Q2
$9K Buy
+91,950
New +$19.7K ﹤0.01% 371

Other funds holding COCHW

Meteora Capital's COCHW Position: Q1 2024 in Review

Meteora Capital sold out of Envoy Medical Warrant (COCHW) in Q1 2024, closing a stake of 133,769 shares — an estimated $2.67K sold.

Meteora Capital first reported a position in COCHW in Q2 2022 and held it in 7 quarters. The position peaked at $11.9K in Q3 2023. 47 funds tracked by Wall St. Rank hold COCHW as of Q1 2024.

  • Meteora Capital reported no remaining Envoy Medical Warrant position as of Q1 2024 after selling out during the quarter.
  • Meteora Capital sold 133,769 Envoy Medical Warrant shares in Q1 2024, an estimated $2.67K.
  • Meteora Capital first reported a position in Envoy Medical Warrant in Q2 2022 and held it in 7 quarters.
  • Meteora Capital's Envoy Medical Warrant position peaked at $11.9K in Q3 2023.
  • 47 funds tracked by Wall St. Rank held Envoy Medical Warrant as of Q1 2024.

Based on Meteora Capital's 13F filing for Q1 2024, filed 14 May 2024.